Minerva Neurosciences, Inc. (NERV)
↓ Download CSV- Sector Manufacturing
- Incorporated MA
- Fiscal year ends Dec 31
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — |
| Operating Income | -$15.10M | -$21.85M | -$23.12M | -$25.23M | -$45.37M | $1.85M | -$75.87M | -$51.73M | -$41.17M | -$30.19M |
| Net Income | -$293.42M | $1.44M | -$30.01M | -$32.11M | -$49.91M | $1.94M | -$72.18M | -$50.17M | -$31.52M | -$31.05M |
| EPS (Diluted) | $-34.67 | $0.19 | $-4.61 | $-6.01 | $-9.35 | $0.05 | $-1.85 | — | — | — |
| Total Assets | $97.97M | $37.14M | $56.90M | $55.09M | $77.12M | $57.63M | $77.50M | $139.14M | $183.70M | $132.94M |
| Total Liabilities | $233.76M | $62.84M | $85.36M | $75.11M | $69.15M | $4.96M | $49.72M | $48.87M | $52.10M | $26.96M |
| Shareholders' Equity | -$140.75M | -$25.69M | -$28.46M | -$20.02M | $7.98M | $52.66M | $27.78M | $90.26M | $131.60M | $105.98M |
| Cash & Equivalents | $82.30M | $21.36M | $40.91M | $36.09M | $60.76M | $25.36M | $21.41M | $50.23M | $26.05M | $82.98M |
| Operating Cash Flow | -$13.51M | -$19.55M | -$14.78M | -$24.65M | -$24.60M | -$33.82M | -$43.43M | -$41.94M | $3.09M | — |
| Capital Expenditures | — | — | — | $16.3K | — | — | — | — | $52.4K | — |
| Shares Outstanding | 43.27M | 6.99M | 6.99M | 5.34M | 5.34M | 42.72M | 39.08M | 38.94M | 38.75M | 35.02M |